Mark G Alexandrow

54PUBLICATIONS
262CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Oral and maxillofacial surgeryPacific Peoples youth and family
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|May 14, 2026
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

|May 04, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

|Apr 23, 2026
Does Longitudinal Targeted Panel Sequencing Provide Clinically Relevant Information in Translocation-Associated Sarcomas?

|Mar 16, 2026
Osteosarcoma is not a single disease: Considerations for multidisciplinary management of jaw (gnathic) osteosarcoma.

Damon R Reed, Emily K Slotkin

|Feb 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.

Evan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand

|Dec 01, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar

Pageof 9

Frequent Collaborators

9 joint publications

Katherine A Janeway

7 joint publications

Richard Gorlick

7 joint publications

Steven G DuBois

6 joint publications

Brian D Crompton